VanEck Biotech ETF
BBH
NASDAQ
Weiss Ratings | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C | |||
Risk Index | Fair | |||
Risk Grade | C- | |||
Valuation | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Price | $160.56 | |||
Company Info | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | VanEck | |||
Manager/Tenure (Years) | Peter H. Liao (12), Griffin Driscoll (0) | |||
Website | http://www.vaneck.com | |||
Phone Number | 800-826-1115 | |||
Fund Information | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | VanEck Biotech ETF | |||
Category | Health | |||
Sub-Category | Healthcare Sector Equity | |||
Prospectus Objective | Specialty - Unaligned | |||
Inception Date | Dec 20, 2011 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | -- | |||
Minimum Subsequent Investment | -- | |||
Front End Fee | -- | |||
Back End Fee | -- | |||
Dividends and Shares | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 0.46% | |||
Dividend | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 0.91% | |||
Asset Allocation | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | -0.01% | |||
Stock | 100.01% | |||
U.S. Stock | 93.68% | |||
Non-U.S. Stock | 6.33% | |||
Bond | 0.00% | |||
U.S. Bond | 0.00% | |||
Non-U.S. Bond | 0.00% | |||
Preferred | 0.00% | |||
Convertible | 0.00% | |||
Other Net | 0.00% | |||
Price History | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 3.85% | |||
30-Day Total Return | -1.46% | |||
60-Day Total Return | -3.22% | |||
90-Day Total Return | -2.92% | |||
Year to Date Total Return | -2.88% | |||
1-Year Total Return | 1.65% | |||
2-Year Total Return | 8.53% | |||
3-Year Total Return | -13.40% | |||
5-Year Total Return | 30.95% | |||
Price | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | $160.56 | |||
1-Month Low Price | $151.99 | |||
1-Month High Price | $162.90 | |||
52-Week Low Price | $143.93 | |||
52-Week Low Price (Date) | Oct 27, 2023 | |||
52-Week High Price | $170.60 | |||
52-Week High Price (Date) | Jan 08, 2024 | |||
NAV | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
1-Month Low NAV | $151.93 | |||
1-Month High NAV | $162.96 | |||
52-Week Low NAV | $143.86 | |||
52-Week Low NAV (Date) | Oct 27, 2023 | |||
52-Week High NAV | $170.57 | |||
52-Week High Price (Date) | Jan 08, 2024 | |||
Beta / Standard Deviation | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.00 | |||
Standard Deviation | 19.38 | |||
Balance Sheet | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 413.00M | |||
Operating Ratios | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 0.35% | |||
Turnover Ratio | 18.00% | |||
Performance | BBH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 41.97% | |||
Last Bear Market Total Return | -10.06% | |||